Csenge Advisory Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,623
| Closed | -$1.05M | – | 769 |
|
|
2024
Q3 | $1.05M | Buy |
+10,623
| New | +$1.05M | 0.05% | 259 |
|
|
2024
Q2 | – | Sell |
-2,186
| Closed | -$207K | – | 760 |
|
|
2024
Q1 | $207K | Buy |
+2,186
| New | +$207K | 0.01% | 668 |
|
|
2022
Q2 | – | Sell |
-10,463
| Closed | -$940K | – | 689 |
|
|
2022
Q1 | $940K | Buy |
+10,463
| New | +$940K | 0.07% | 232 |
|
|
2019
Q2 | – | Sell |
-19,247
| Closed | -$1.74M | – | 221 |
|
|
2019
Q1 | $1.74M | Sell |
19,247
-257
| -1% | -$23.3K | 0.6% | 31 |
|
|
2018
Q4 | $1.4M | Buy |
19,504
+2,486
| +15% | +$178K | 0.51% | 40 |
|
|
2018
Q3 | $1.28M | Buy |
17,018
+329
| +2% | +$24.6K | 0.5% | 41 |
|
|
2018
Q2 | $1.59M | Buy |
16,689
+399
| +2% | +$38K | 0.58% | 41 |
|
|
2018
Q1 | $1.43M | Sell |
16,290
-854
| -5% | -$74.9K | 0.5% | 49 |
|
|
2017
Q4 | $1.46M | Sell |
17,144
-1,738
| -9% | -$148K | 0.52% | 48 |
|
|
2017
Q3 | $1.63M | Buy |
+18,882
| New | +$1.63M | 0.65% | 33 |
|